Knee osteoarthritis: avocado-soybean oil supplement safe, efficacious in meta-analysis

  • Simental-Mendía M & al.
  • Int J Rheum Dis
  • 22 Jul 2019

  • International Clinical Digest
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • A nutraceutical supplement consisting of avocado-soybean unsaponifiables (ASU) is safe and reduces the pain, severity of knee osteoarthritis (KOA), but not hip OA, according to a meta-analysis.

Why this matters

  • ASU therapy may be a natural, short-term treatment option for KOA.

Study design

  • Meta-analysis of 5 randomized, placebo-controlled trials (n=1095) after search of Medline, SCOPUS, Web of Science, and Google Scholar.
  • Outcomes include change in pain by visual analog scale (VAS; 1-100 mm), in severity by Lequesne index (0-24), and/or joint space width (JSW).
  • Typical ASU dose was 300-600 mg/day.
  • Funding: None disclosed.

Key results

  • ASU (vs placebo) supplementation displayed a reduction in VAS (weighted mean difference [WMD], −9.64 mm; P=.02; I2=92%) and in the Lequesne index (WMD, −1.56; P=.0002; I2=78%).
    • A subanalysis only found improvement in KOA (VAS: WMD, −17.36 mm; P<.0001 i>2=87% and Lequesne index: WMD, −2.33; P<.00001 i>2=18%), but not in hip OA.
  • ASU (vs placebo) had no effect on JSW (P=.14).
  • ASU was no different from placebo in terms of adverse events (risk ratio, 1.02; P=.88; I2=0%).

Limitations

  • Follow-up was short-, not long-term.
  • High heterogeneity.
  • Small number of trials.